The post Eli Lilly secures weight loss drug approval in China: How do rivals stack up? appeared first on Invezz ...

Novo Nordisk announced in June that its weight-loss drug Wegovy received similar approval in China. Eli Lilly and Co. (LLY) announced on its WeChat account Friday that it has won approval from ...

also approved in China, and weight-loss drug Zepbound. Eli Lilly and Novo Nordisk are racing to increase production in a weight-loss market estimated to reach at least $100 billion globally by the ...

Eli Lilly & Co.’s Mounjaro ... s most severely hit by obesity. China’s National Medical Products Administration approved Lilly’s shot for long-term weight management on Friday, the company ...

The move intensifies the competition with Eli Lilly, which secured approval for its weight-loss drug in China in July but has yet to launch it. Both companies are ramping up production to ...

Compounded GLP-1s are still accessible on telehealth sites, despite an agreement with Eli Lilly to cease copycat sales.

The global market for diabetes drugs used for treating obesity is expected to expand in Asia, as new players jostle with giants Eli Lilly and ... The market for weight-loss drugs could see new ...

The two-year shortage of Eli ... t yet clear. Many patients still report difficulty getting the drugs despite Lilly saying there’s enough. Pharmacies that make copies of the weight-loss and ...